Analysis of blood samples from 149 ICI-treated NSCLC patients demonstrated that responders had significantly lower expression of exosomal PD-L1 protein than non-responders at pre-treatment [137]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.